Filing Flows › Comparisons › BTMD vs MRMD
biote vs Marimed: BTMD and MRMD compared
biote is the larger company: $43.3M of revenue in its latest quarter (Q3 2026) against $41.9M for Marimed (Q2 2026). Marimed is growing faster (+6% against -10% a year earlier). biote is more profitable, with an operating margin of 5.7% against 1.0%.
Where the money goes: BTMD and MRMD
biote (BTMD) · Q3 2026
biote, Q3 2026: revenue $43.3M (-10% year over year), operating margin 5.7%, net earnings $407K, operating cash flow $3.7M. The chart follows the revenue to costs, profit and cash.
Marimed (MRMD) · Q2 2026
Marimed, Q2 2026: revenue $41.9M (+6% year over year), operating margin 1.0%, net loss $3.6M, operating cash flow $2.2M. The chart follows the revenue to costs, profit and cash.
| biote (BTMD) | Marimed (MRMD) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $43.3M | $41.9M |
| Revenue growth, Y/Y | -10% | +6% |
| Operating margin | 5.7% | 1.0% |
| Net earnings | $407K | −$3.6M |
| Net margin | 0.9% | -8.5% |
| Operating cash flow | $3.7M | $2.2M |
| Free cash flow | $1.1M | $1.9M |
Where the revenue comes from
biote
- Product revenue: $42.6M (98%)
- Service revenue: $765K (2%)
Marimed
- Product sales - retail: $23.2M (55%)
- Product sales - wholesale: $18.5M (44%)
- Other revenue: $193K (0%)
Questions
Which is bigger, biote or Marimed?
biote is the larger company: $43.3M of revenue in its latest quarter (Q3 2026) against $41.9M for Marimed (Q2 2026).
Is biote or Marimed growing faster?
Marimed is growing faster (+6% against -10% a year earlier).
Which is more profitable, biote or Marimed?
biote is more profitable, with an operating margin of 5.7% against 1.0%.
More: biote earnings · how biote makes money · Marimed earnings · how Marimed makes money
From the companies' latest 10-Q, 10-K or earnings release (8-K filed Nov 4, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.